| Literature DB >> 35922465 |
Sebastian Rohe1, Nicoletta Dörr2, Sabrina Böhle2, Georg Matziolis2, Steffen Brodt2, Eric Röhner3.
Abstract
Acetabular defects are a challenging condition for surgeons in revision THA. A crucial aim is an anatomical restoration of the centre of rotation (COR) through grafts. The aim of this study was to determine the cup survival after biological restoration of acetabular defects in THA and the effect of Paprosky classification, age, BMI, and number of previous operations on cup survival. Retrospectively patients with a cup exchange and an impaction of cortico-cancellous or bulk grafts between 2009 and 2012 were included with a follow up with a minimum of 5 year. Implant failure was defined as radiographic loosening or explantation of the cup. The acetabular defect situation was classified to Paprosky. 82 patients (58 female 70.7%) were included. 26 patients were not available to contact. 56 patients (40 female 71.4%) remained for survival analysis with mean age of 75.6 ± 8 years. Survival of the cup after 5 years was 90% and after 7.8 years 88%. There was no difference in survival concerning defect classification, type of implant or graft, age, BMI, and number of previous operations. Patients on the follow up reached an HHS of 67.4 ± 19, a WOMAC Score of 33.4 ± 25.4 points and an unsatisfactory result in the SF-36. Impaction bone grafting of acetabular defects is a good option with satisfactory biomechanical results and survival for small defects. Predictive factors for cup survival could not be clarified in our study. So, the correct indication, knowing the limits of the methods and the correct choice of implant allow a defect-oriented approach and are decisive for the success of the operation.Entities:
Mesh:
Year: 2022 PMID: 35922465 PMCID: PMC9349309 DOI: 10.1038/s41598-022-17526-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Flowchart of case inclusion and exclusion.
Baseline characteristics.
| N | Complete | Male | Female | |
|---|---|---|---|---|
| Age (years) | 82 | 70.3 ± 9.0 | 69.1 ± 7.6 | 70.8 ± 9.5 |
| Size (cm) | 82 | 163.3 ± 9.7 | 171.8 ± 8.7 | 159.9 ± 7.8 |
| Weight (kg) | 82 | 74.8 ± 14.9 | 83.1 ± 15.5 | 71.3 ± 13.3 |
| BMI (kg/m2) | 82 | 28.0 ± 4.8 | 28.0 ± 4.4 | 27.9 ± 5.0 |
| Normal weight | 82 | 30.5% | 29.2% | 31.0% |
| Overweight | 82 | 36.6% | 33.3% | 37.9% |
| Obesity I° | 82 | 26.8% | 33.3% | 24.1% |
| Obesity II° | 82 | 3.7% | 4.2% | 3.4% |
| Obesity III° | 82 | 2.4% | 0.0% | 2.4% |
| Arterial hypertension | 60 | 73.2% | ||
| Coronary syndrome | 9 | 11.0% | ||
| Cardiac arrhythmias | 8 | 9.8% | ||
| Heart failure | 5 | 6.1% | ||
| Diabetes mellitus | 17 | 20.7% | ||
| Thyroid disease | 14 | 17.1% | ||
| Malignancy | 7 | 8.5% | ||
| COPD | 5 | 6.1% | ||
| Renal failure | 3 | 3.7% | ||
| Immunosuppression | 3 | 3.7% | ||
| Osteopenia or osteoporosis | 19 | 23.2% | ||
| Rheumatoid arthritis | 7 | 8.5% | ||
Figure 2Previous operations before study index operation.
Figure 3Categorized implants of implanted cups.
Figure 4Revision strategy depending on Paprosky classification.
Figure 5Kaplan–Meier-curve for general cup survival.
Figure 6Kaplan–Meier-curve for cup survival based on aseptic loosening or acetabular fracture.
Figure 7Preoperative Paprosky type 3a defect and postoperative controls after 1 week and 6 years.
Figure 8Preoperative Paprosky type 3a defect and postoperative controls after 1 week and 7.6 years.
Figure 9Preoperative Paprosky type 3a defect and postoperative controls after 1 week and 1.5 years with renewed cup loosening.
SF-36 questionnaire.
| Study sample | German normal sample | German normal sample age > 70 years | |||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Mean ± SD | z-value | N | Mean ± SD | N | Mean ± SD | |||
| KOEFU | 16 | 46.88 ± 32.96 | − 1.84 | 2886 | 85.71 ± 22.10 | 326 | 58.59 ± 27.44 | 0.0998 | |
| KOERO | 16 | 37.50 ± 43.78 | − 1.25 | 2856 | 83.70 ± 31.73 | 317 | 62.16 ± 40.80 | ||
| SCHM | 16 | 48.44 ± 30.38 | − 1.11 | 2905 | 79.08 ± 27.38 | 327 | 64.20 ± 28.13 | ||
| AGES | 16 | 43.06 ± 18.15 | − 1.48 | 2859 | 68.05 ± 20.15 | 324 | 55.30 ± 20.96 | ||
| VITA | 16 | 49.06 ± 20.10 | − 0.51 | 2876 | 63.27 ± 18.47 | 324 | 53.91 ± 21.39 | 0.3753 | |
| SOFU | 16 | 80.50 ± 30.62 | − 0.18 | 2911 | 88.76 ± 18.40 | 0.0747 | 328 | 83.94 ± 21.27 | 0.5374 |
| EMRO | 16 | 64.50 ± 39.47 | − 0.67 | 2855 | 90.35 ± 25.62 | 320 | 83.04 ± 33.72 | ||
| PSYC | 16 | 65.00 ± 19.57 | − 0.54 | 2871 | 73.88 ± 16.38 | 324 | 71.41 ± 17.21 | 0.1494 | |
Significant values are in [bold].
KOEFU physical function, KOERO physical role, SCHM bodily pain, AGES general health, VITA vitality, SOFU social function, EMRO emotional role, PSYC mental health.
Review of cup survival in literature.
| Follow up (y) | N | Classification | Cup survival/failure rate | |
|---|---|---|---|---|
| Della Valle et al.[ | 15 | 138 | Pap. I–IIIB | Survival: 81% |
| Aseptic Survival: 96% | ||||
| Jones and Lachiewicz[ | 12 | 211 | AAOS I–IV | Survival: 95% |
| Aseptic Survival: 98% | ||||
| Perka and Ludwig[ | 5.5 (3–10) | 63 | Pap. IIA–IIIB | Survival: 88.8% |
| Aseptic loosening: 4.8% | ||||
| Winter et al.[ | 7.3 | 38 | AAOS II, IV | Aseptic loosening: 0% |
| Marx et al.[ | 7 | 74 | AAOS III | Aseptic loosening: 6.2% |
| Wachtl et al.[ | 12 (8–21) | 38 | AAOS II–IV | Survival 92% (21 y) |
| Schlegel et al.[ | 6 (2–17) | 122 | AAOS I–IV | Aseptic survival: 98% (5 y), 95% (8 y) |
| Gerber et al.[ | 9 (7.8–11.6) | 50 | AAOS II–IV | Survival: 81% (10 y) |
| Regis et al.[ | 11.7 (10–14.4) | 56 | Pap. IIIA–IIIB | Survival: 87.5% |
| Aseptic loosening: 8.9% | ||||
| Regis et al.[ | 14.6 (10–18.9) | 65 | Pap. IIIA–IIIB | Survival: 80% (18.9 y) |
| Aseptic survival: 84.6% (18.9 y) | ||||
| Whitehouse et al.[ | 7–11 | 40 | Pap. IIA–IIIB | Survival: 87% (10 y) |
| Survival graft: 92% (10 y) | ||||
| Jenkins et al.[ | 5–12.5 | 58 | Pap. IIA–IIIB | Survival: 100% (5 y), 97% (10 y) |
| Löchel et al.[ | 10 | 53 | Pap. IIA–IIIB | Survival: 92.5% |